Clinical Trial Update: Home Reported Outcomes in PNH

View source ↗

Summary

Clinical trial update indicating a Novartis-sponsored study on home-reported outcomes in paroxysmal nocturnal hemoglobinuria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: RECRUITING